Liquid Plasma/Serum Stabiliser 50ml

85,00 excl. Vat

Categories: ,

Liquid Serum/Plasma Stabiliser – 50 ml


STORAGE: 2 – 8 °C, protect from sun light



BioThinX proprietary Liquid Plasma/Serum Stabiliser protects biological activity in liquid protein formulations by inhibiting protein aggregation, denaturation, and microbial contamination. The method is based on the thermodynamic effect of compatible solutes exclusion, which shifts native proteins toward more compact conformations.  

Liquid protein stabilisation is used to stabilise the structure and biological activity of purified proteins and complex biological samples, and is applicable for prolonged storage of antibodies, enzymes, or biomarkers in liquid formulations to avoid detrimental freeze thaw cycles.



This product is for R&D use only, not for drug, household, or other uses. Please consult the Material Safety Data Sheet for information regarding hazards and safe handling practices.



Liquid Serum/Plasma Stabiliser is stable for shipping at ambient temperature. The product contains a HEPES, NaCl, small molecule buffer base at neutral pH.



To stabilize serum or plasma samples in liquid form add the stabilizer solution 1:1 to the serum or plasma sample.  

Mix gently and store the stabilized samples at 2-8 °C in airtight vials.



For long term storage the product should be stored between 2 °C and 8 °C.



Ready-to-use solution, use one of the stabiliser solution to one part serum or plasma sample.



1. Hengherr, S., et al., High-temperature tolerance in anhydrobiotic tardigrades is limited by glass transition, Physiol. Biochem. Zool., 82, 749-755 (2009).

2. Koubaa, S., er al., Structural properties and enzyme stabilization function of the intrinsically disordered LEA_4 protein TdLEA3 from wheat, Nature Scientific Reports, (9) Article number: 3720 (2019).

3. Carpenter, J., F., Comparison of solute-induced protein stabilization in aqueous solution and in the frozen and dried states,

J. Dairy Sci. 73, 3627-3636 (1990)

4. Killian, M., S., Stabilization of dry protein coatings with compatible solutes,

Biointerphases, 13(6), 06E401 (2018)



BioThinx warrants, that at the time of the quality release or subsequent retest date this product conformed to the information contained in this publication. Purchaser must determine the suitability of the product(s) for its particular use. Additional terms and conditions may apply. Please see reverse side of the invoice or packing slip.